flibanserin

Known as: 1-(2-(4-(3-trifluoromethylphenyl)piperazin-1-yl)ethyl)benzimidazol(1H)-2-one 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
There have been several products developed for male sexual dysfunction. However, developing agents for female sexual dysfunction… (More)
Is this relevant?
2014
2014
OBJECTIVE This study aimed to assess the efficacy and safety of flibanserin, a serotonin receptor 1A agonist/serotonin receptor… (More)
  • figure 1
  • table 2
  • table 1
  • figure 2
  • figure 3
Is this relevant?
2013
2013
INTRODUCTION Hypoactive Sexual Desire Disorder (HSDD) is characterized by low sexual desire that causes marked distress or… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2012
Highly Cited
2012
INTRODUCTION Hypoactive sexual desire disorder (HSDD) is the most common form of female sexual dysfunction and is characterized… (More)
Is this relevant?
2012
2012
INTRODUCTION Hypoactive Sexual Desire Disorder (HSDD) is a common form of Female Sexual Dysfunction characterized by low sexual… (More)
Is this relevant?
2012
2012
INTRODUCTION Hypoactive Sexual Desire Disorder (HSDD) is characterized by low sexual desire that causes marked distress or… (More)
Is this relevant?
2011
2011
INTRODUCTION Flibanserin is a 5-HT(1A) agonist/5-HT(2A) antagonist that has been shown to increase sexual desire and reduce… (More)
Is this relevant?
2010
2010
INTRODUCTION Flibanserin, a novel 5-HT(1A) agonist and 5-HT(2A) antagonist, has the potential to treat sexual dysfunction. AIM… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Antidepressants, such as serotonin or noradrenaline reuptake inhibitors (e.g. fluoxetine, nefadozone) or 5-HT1A agonists… (More)
Is this relevant?
Review
2002
Review
2002
Flibanserin has preferential affinity for serotonin 5-HT(1A), dopamine D(4k), and serotonin 5-HT(2A) receptors. In vitro and in… (More)
Is this relevant?